Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |